CalciMedica Overview
- Year Founded
-
2006

- Status
-
Public
- Employees
-
13

- Stock Symbol
-
CALC

- Investments
-
1
- Share Price
-
$2.75
- (As of Monday Closing)
CalciMedica General Information
Description
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.
Contact Information
Website
www.calcimedica.comCorporate Office
- 505 Coast Boulevard South
- Suite 307, La Jolla
- San Diego, CA 92037
- United States
Corporate Office
- 505 Coast Boulevard South
- Suite 307, La Jolla
- San Diego, CA 92037
- United States
CalciMedica Timeline
CalciMedica Stock Performance
As of 10-Feb-2025, CalciMedica’s stock price is $2.75. Its current market cap is $37.1M with 13.5M shares.
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$2.75 | $2.67 | $2.05 - $6.26 | $37.1M | 13.5M | 46.1K | -$1.11 |
CalciMedica Financials Summary
As of 30-Sep-2024, CalciMedica has a trailing 12-month revenue of null.
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 28,486 | 1,668 | (32,544) | (33,539) |
Revenue | 0 | 0 | 0 | 0 |
EBITDA | (13,525) | (34,189) | (7,640) | (35,428) |
Net Income | (13,588) | (34,357) | (7,824) | (35,821) |
Total Assets | 16,212 | 12,185 | 3,349 | 69,088 |
Total Debt | 0 | 0 | 5,157 | 0 |
CalciMedica Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
CalciMedica Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
CalciMedica Comparisons
Industry
Financing
Details
CalciMedica Competitors (49)
One of CalciMedica’s 49 competitors is AnTolRx, a Venture Capital-Backed company based in Cambridge, MA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
AnTolRx | Venture Capital-Backed | Cambridge, MA | ||||
Parion Sciences | Venture Capital-Backed | Durham, NC | ||||
NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
Topas Therapeutics | Venture Capital-Backed | Hamburg, Germany | ||||
Cristal Therapeutics | Venture Capital-Backed | Maastricht, Netherlands |
CalciMedica Signals
CalciMedica Acquisitions (1)
CalciMedica’s most recent deal was a Merger/Acquisition with Graybug Vision. The deal was made on 20-Mar-2023.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Graybug Vision | 20-Mar-2023 | Merger/Acquisition | Drug Delivery |
CalciMedica ESG
Risk Overview
Risk Rating
Updated June, 08, 2021
39.86 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,042
Rank
Percentile

Pharmaceuticals
Industry
of 947
Rank
Percentile

Biotechnology
Subindustry
of 452
Rank
Percentile

CalciMedica FAQs
-
When was CalciMedica founded?
CalciMedica was founded in 2006.
-
Where is CalciMedica headquartered?
CalciMedica is headquartered in San Diego, CA.
-
What is the size of CalciMedica?
CalciMedica has 13 total employees.
-
What industry is CalciMedica in?
CalciMedica’s primary industry is Drug Discovery.
-
Is CalciMedica a private or public company?
CalciMedica is a Public company.
-
What is CalciMedica’s stock symbol?
The ticker symbol for CalciMedica is CALC.
-
What is the current stock price of CalciMedica?
As of 10-Feb-2025 the stock price of CalciMedica is $2.75.
-
What is the current market cap of CalciMedica?
The current market capitalization of CalciMedica is $37.1M.
-
Who are CalciMedica’s competitors?
AnTolRx, Parion Sciences, NexImmune, Topas Therapeutics, and Cristal Therapeutics are some of the 49 competitors of CalciMedica.
-
What is CalciMedica’s annual earnings per share (EPS)?
CalciMedica’s EPS for 12 months was -$1.11.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »